Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Raleigh. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Raleigh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Check if you qualify for this crohn's disease clinical trial in Raleigh, NC
If you're searching for crohn's disease treatment options in Raleigh, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Raleigh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.